Bank of Montreal Can raised its stake in CME Group Inc. (NASDAQ:CME) by 3.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 366,925 shares of the financial services provider’s stock after buying an additional 13,941 shares during the period. Bank of Montreal Can’s holdings in CME Group were worth $45,953,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Huntington National Bank boosted its stake in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares in the last quarter. Coconut Grove Bank boosted its stake in shares of CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after buying an additional 440 shares in the last quarter. Whittier Trust Co. boosted its stake in shares of CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock worth $122,000 after buying an additional 115 shares in the last quarter. Parallel Advisors LLC boosted its stake in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares in the last quarter. Finally, RidgeWorth Capital Management LLC boosted its stake in shares of CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after buying an additional 406 shares in the last quarter. Hedge funds and other institutional investors own 83.07% of the company’s stock.

CME Group Inc. (CME) opened at 120.57 on Monday. The stock has a 50 day moving average price of $120.94 and a 200-day moving average price of $119.90. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96. The firm has a market cap of $40.97 billion, a price-to-earnings ratio of 26.10 and a beta of 0.74.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, April 27th. The financial services provider reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.02. The business had revenue of $929 million for the quarter, compared to the consensus estimate of $932.06 million. CME Group had a return on equity of 7.43% and a net margin of 43.62%. The business’s revenue was down .5% on a year-over-year basis. During the same quarter last year, the business posted $1.15 EPS. Equities analysts forecast that CME Group Inc. will post $4.86 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, June 26th. Investors of record on Friday, June 9th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 2.19%. The ex-dividend date was Wednesday, June 7th. CME Group’s dividend payout ratio (DPR) is 57.14%.

ILLEGAL ACTIVITY WARNING: “CME Group Inc. (NASDAQ:CME) Position Increased by Bank of Montreal Can” was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/07/17/cme-group-inc-nasdaqcme-position-increased-by-bank-of-montreal-can.html.

A number of equities research analysts have weighed in on the company. UBS AG reiterated a “buy” rating and issued a $134.00 price objective (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Deutsche Bank AG reduced their price objective on CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research note on Tuesday, July 4th. Jefferies Group LLC reiterated a “buy” rating and issued a $128.00 price objective on shares of CME Group in a research note on Monday, July 10th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $127.00 price objective on shares of CME Group in a research note on Friday. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $127.33.

In related news, Director Dennis Suskind sold 1,099 shares of the firm’s stock in a transaction that occurred on Friday, April 28th. The stock was sold at an average price of $115.29, for a total value of $126,703.71. Following the sale, the director now owns 5,000 shares of the company’s stock, valued at approximately $576,450. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Derek Sammann sold 2,100 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $117.86, for a total value of $247,506.00. Following the completion of the sale, the insider now directly owns 31,026 shares in the company, valued at approximately $3,656,724.36. The disclosure for this sale can be found here. In the last three months, insiders sold 48,754 shares of company stock worth $5,955,724. Company insiders own 0.61% of the company’s stock.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.